Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

AURORA CANNABIS INC (ACB) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Aurora Cannabis Inc. Announces Closing of its C$38.8 Million Bought Deal Financing, Including the Full Exercise of the Over-Allotment Option Intends to Repay Remaining Convertible Debt Balance, Saving Almost C$2 Million in Annual Interest Payments Edmonton, AB - October 3, 2023 - Aurora Cannabis Inc. , the Canadian company opening the world to cannabis, today announced the closing of its previously announced bought deal offering of 53,187,500 common shares of the Company at a price of C$0.73 per Offered Security , for aggregate gross proceeds to Aurora of approximately C$38,826,875 . The gross proceeds include the full exercise of the over-allotment option by Canaccord Genuity to purchase 6,937,500 additional common shares of the Company on the same terms as the Offering. “It is our intent..."
09/28/2023 6-K Quarterly results
08/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Condensed Consolidated Interim Financial Statements for the three months ended June 30, 2023 and 2022",
"Interim Management’ s Discussion and Analysis for the three months ended June 30, 2023 and 2022",
"Certification of Chief Executive Officer",
"Certification of Chief Financial Officer"
08/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Achieves Quarterly Net Revenue 1 of $75.1 Million; Strong YoY Growth Across All Business Units; Global Medical Cannabis +14%, Consumer Cannabis +5%, Plant Propagation +12% Delivers Third Sequential Quarter of Positive Adjusted EBITDA 1 , Supported by Bevo's Record Quarterly Revenue"
07/24/2023 6-K Quarterly results
07/19/2023 6-K Quarterly results
07/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Management Information Circular",
"Proxy Form",
"Notice and Access Letter",
"Virtual AGM User Guide",
"Voting Instruction Form"
06/07/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Aurora Cannabis to Host Third Quarter and Fiscal Year 2023 Investor Conference Call and File Related Year End Information"
05/25/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Notice of Meeting and Record Date"
04/24/2023 6-K Quarterly results
02/22/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Canada's leading medical cannabis provider and Australia's preeminent medical cannabis supplier to bring three new premium strains to Australian patients"
02/10/2023 6-K Quarterly results
02/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Cannabis Revenues Up ~20% from Fiscal Q1 2023, Net Revenue 1 of $61.7 Million Achieves Positive Adjusted EBITDA 1 in Line with Prior Guidance Delivers ~$340 Million in Annualized Cost Savings Since February 2020"
01/26/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"NEWS RELEASE DATED JANAURY 26, 2023"
01/04/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"NEWS RELEASE DATED JANAURY 4, 2023"
12/05/2022 6-K Quarterly results
11/25/2022 6-K Quarterly results
11/14/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Forward-looking Information"
11/14/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Report on Voting Results"
11/14/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Condensed Consolidated Interim Financial Statements for the three months ended September 30, 2022",
"Interim Management’ s Discussion and Analysis for the three months ended September 30, 2022",
"Certification of Chief Executive Officer",
"Certification of Chief Financial Officer"
11/10/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Reiterates Reaching Adjusted EBITDA Profitability by December 31, 2022 Reaffirms $150 to $170 Million in Annualized Cost Savings Achieved by December 31, 2022; $140 Million Realized to Date"
10/31/2022 6-K Quarterly results
10/07/2022 6-K Quarterly results
10/05/2022 6-K Quarterly results
09/20/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Cannabis Net Revenue Increased 35.4% from Q4 2021 and 70.3% from Fiscal 2021 Reiterates Adjusted EBITDA Profitability Run Rate by December 31, 2022"
09/06/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Material Change Report"
08/29/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Aurora Cannabis to Host Fourth Quarter and Full Fiscal Year 2022 Investor Conference Call and Related Year End Informational Filings"
08/29/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Notice of Meeting and Record Date"
08/29/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Long Term Investment Expected to Deliver Aurora Immediate Positive Cash Flow"
06/03/2022 6-K Quarterly results
06/01/2022 6-K Quarterly results
06/01/2022 6-K Quarterly results
05/31/2022 6-K Quarterly results
05/27/2022 6-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy